Q-linea

medical devices

About

Q-linea is a Swedish infection diagnostics company founded in 2008 by scientists from Uppsala University. The company focuses on improving sepsis treatment and antibiotic usage through rapid and accurate diagnostic solutions. Their flagship product, ASTar™, is a fully automated instrument that performs antibiotic susceptibility testing directly from positive blood cultures, providing results in about 3 to 6 hours, much faster than traditional methods. Operating from Uppsala Science Park, Q-linea collaborates strategically to enhance clinical evaluation and market reach. They employ a commercial strategy that includes direct sales and partnerships, notably with Thermo Fisher Scientific, to expand their global presence. Q-linea serves healthcare providers and clinical laboratories worldwide, aiming to improve patient outcomes and reduce unnecessary antibiotic use, thus addressing antibiotic resistance.

Technologies

Outlook DigitalOcean WordPress.org Nginx Google Font API Multilingual Google Tag Manager YouTube Mobile Friendly reCAPTCHA

Keywords

medical devices biotechnology rapid ast clinical microbiology antimicrobial resistance eucast breakpoint updates microbiology workflow automation medical equipment and supplies manufacturing blood culture testing antimicrobial resistance monitoring time-critical sepsis diagnostics medical technology sepsis treatment support infection control innovation phenotypic antibiotic testing broad antimicrobial panels microbiology laboratory automation diagnostics ce-ivd marked antibiotic resistance standardized inoculum infection diagnostics blood culture from positive samples b2b blood culture analysis sepsis rapid testing laboratory automation in vitro diagnostic (ivd) hospital laboratory integration rapid diagnostic technology

Location

52A Dag Hammarskjoelds vaeg, Uppsala, Uppsala County, Sweden, 752 37

Related Companies

Companies in the same industry